Polymyxin B Injection, Powder, Lyophilized, For Solution
Product Images NDC 72266-249

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Polymyxin B (NDC 72266-249). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fosun Pharma Usa Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Label (Carton Label)

Packaging label for Polymyxin B for Injection, USP, 500,000 units per vial, lyophilized powder for solution. The label indicates it is for hospital use only, prescribed for intramuscular, intravenous, and/or intrathecal administration. Distributed by Fosun Pharma USA Inc, made in India. Package contains 10 sterile vials.*

FDA Label Image

Vial Label (Vial Label)

Label for Polymyxin B for Injection, USP, a lyophilized sterile powder for solution with a strength of 500,000 units per vial. Distributed by Fosun Pharma USA Inc., made in India. The label includes storage instructions, usage routes (intramuscular, intravenous, intrathecal), dosage warnings, and barcode information. It is for hospital use only.*

FDA Label Image

Poly-spl-structure (Poly Spl Structure)

Chemical structure diagram of Polymyxin B showing Polymyxin B1 with R=CH3 and Polymyxin B2 with R=H, including amino acid residues Dab, Thr, Phe, and Leu, and sulfate groups represented as xH2SO4.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.